Brookfield Corporation

NYSE:BN

Asset Management

Financial Services
$39.39 -0.72%

-$0.32 today

Market cap
$87.93B
Beta
1.84
P/E (TTM)
83.3
EPS (TTM)
$0.53
Dividend yield
0.59%
52W Low $37.93High $49.57

Volume 2.78M

Average 5.35M

BN Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Brookfield CorporationNYSE: BN

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How BN compares with its peers on the latest reported figures

  • BN's LTM Sep 2026 research & development of $0 is the highest of the 8 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for BN, versus a peer median of 0.0%.
BN Competitors Peer median
Research & Development for BN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BNBrookfield CorporationLTM Sep 2026$0 ——0.0%
BXBlackstone Inc.LTM Sep 2026$0 ——0.0%
KKRKKR & Co. Inc.LTM Sep 2026$0 ——0.0%
APOApollo Global Management, Inc.LTM Jun 2026$0 ——0.0%
ARESAres Management CorporationLTM Jun 2026$0 ——0.0%
PSPershing Square Inc.LTM Jun 2026$0 ——0.0%
OWLBlue Owl Capital Inc.LTM Jun 2026$0 ——0.0%
CGThe Carlyle Group Inc.LTM Sep 2026$0 ——0.0%
Peer median (excluding BN) $0——0.0%

Competitors are the stored peer set for BN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue75.73B92.77B95.92B86.01B75.1B
Cost of Revenue64B78.51B81.41B67.94B56.97B
Gross Profit11.73B14.26B14.52B18.07B18.13B
Gross Margin15.5%15.4%15.1%21.0%24.1%
Research & Development00000
Selling, General & Admin116M122M69M76M78M
Operating Expenses116M122M69M76M78M
Depreciation & Amortization6.44B7.68B9.08B9.74B10.38B
EBITDA28.75B25.05B30.69B29.19B31.85B
EBITDA Margin38.0%27.0%32.0%33.9%42.4%
Operating Income11.62B14.14B14.45B17.99B18.05B
Operating Margin15.3%15.2%15.1%20.9%24.0%
Interest Income00000
Interest Expense7.6B10.7B15.5B16.62B17.1B
Other Income / Expenses3.1B(7.47B)(8.33B)(15.16B)(13.68B)
Income Before Tax14.71B6.66B6.12B2.84B4.37B
Pre-Tax Margin19.4%7.2%6.4%3.3%5.8%
Income Tax Expense2.32B1.47B1.01B982M1.14B
Net Income3.97B2.06B1.13B641M1.31B
Net Margin5.2%2.2%1.2%0.7%1.7%
EPS (Basic)1.650.810.410.210.51
EPS (Diluted)1.590.790.410.210.49
Weighted Avg Shares2.3B2.35B2.34B2.27B2.25B
Weighted Avg Shares (Diluted)2.38B2.41B2.38B2.38B2.37B

Brookfield Corporation

NYSE:BN

Intrinsic Alpha fair value

Locked

Current Price

$39.39

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.